Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 382.35
-5.40 (-1.39%)
At close: Oct 1, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 49.76 billion as of October 2, 2026. Its market cap has increased by 15.02% in one year.
Market Cap
49.76B
Enterprise Value
51.32B
Revenue
1.74B
Ranking
n/a
PE Ratio
85.52
Stock Price
382.35
ChartMarket Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 49.76B, an increase of 142,898.93%. That is a compound annual growth rate of 34.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 49.76B | 3.22% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 274.47B |
| Shilpa Medicare | 204.53B |
| Suven Life Sciences | 90.42B |
| Symbiotec Pharmalab | 75.61B |
| IOL Chemicals and Pharmaceuticals | 60.82B |
| NGL Fine-Chem | 17.97B |
| Bajaj HealthCare | 10.98B |
| Shree Ganesh Remedies | 8.81B |